Low-Dose Radiation Therapy for Refractory Hand Osteoarthritis: A Case Report
This case report describes a 70-year-old woman with severe, refractory hand osteoarthritis and contraindications to standard therapies who achieved significant, though partially durable, pain relief and functional improvement after undergoing low-dose radiation therapy, highlighting its potential as a viable option for select patients while underscoring the need for further research to define optimal patient phenotypes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of older adults, the simple act of gripping a coffee cup or turning a doorknob can become a source of sharp, grinding pain. This is the reality of hand osteoarthritis, a condition where the protective cartilage that cushions the joints wears away, allowing bone to rub against bone. While the condition is common, the standard ways to manage it often fall short. Doctors typically recommend rest, exercises, or painkillers, but many patients cannot take strong anti-inflammatory medicines because of stomach issues or other health risks. When pain becomes severe and unmanageable, and when surgery is not a viable option, patients are often left with few choices. In recent years, a treatment that sounds more like it belongs in cancer care than in a rheumatologist's office has re-emerged as a potential solution: low-dose radiation therapy. Unlike the high doses used to destroy tumors, this approach uses very small amounts of energy, just enough to calm the inflammation inside the joint without damaging the surrounding tissue.
This story begins with a seventy-year-old woman who had been battling severe, worsening pain in her hands for over fifteen years. Her condition was particularly difficult because it involved a specific, aggressive type of arthritis that erodes the bone, causing deformities in the small joints of her fingers and the base of her thumb. She had tried almost everything available to her. She received numerous steroid injections into her joints, but the relief was fleeting. She underwent surgery to remove cysts and clean out the damaged tissue, yet the pain returned within weeks. She could not take standard pain medications because she had a history of bleeding stomach ulcers, and other advanced drug therapies were blocked by insurance hurdles. By late 2025, her pain was so intense that it kept her awake at night and prevented her from performing basic daily tasks. Her doctors, having exhausted the usual options, turned to a therapy that had been used in Europe for decades but was still relatively new in the United States: low-dose radiation.
The treatment plan was precise and gentle. Over the course of two weeks, the woman received six small sessions of radiation directed at both of her hands. Each session delivered a tiny dose of energy, totaling three units of radiation over the entire course. To put this in perspective, the amount of radiation she received was far less than what is used to treat cancer, designed instead to soothe the inflamed tissue rather than destroy it. The results were striking. By the middle of the treatment, her pain, which she had rated as a seven out of ten, began to drop. By the time the two weeks were over, the pain had subsided significantly. In the months that followed, she reported that the pain had almost completely vanished. More importantly, her ability to function returned; she could grip objects firmly again, and for the first time in years, she was able to sleep through the night without waking up in agony. She experienced no side effects from the radiation.
However, the story does not end with a permanent cure. About two months after the treatment finished, the woman noticed the pain returning, though it was milder than before, settling at a level of four out of ten. This partial return of symptoms is not uncommon with this type of therapy, and it suggests that while the treatment can provide significant relief, it may not be a one-time fix for everyone. The medical team is now considering whether a second round of the same treatment could help again. This case highlights a specific group of patients who might benefit most: those with severe, erosive arthritis who have no other safe options for pain relief. While large studies have shown mixed results on whether this therapy works for everyone, this patient's experience suggests that for those with limited choices, it can offer a meaningful window of relief and a return to quality of life. The medical community continues to study who is most likely to respond to this approach, but for this woman, it provided a path forward when all others seemed closed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.